Humana Free cash flow increased by 35.5% to $1.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 380.1%, from $236.00M to $1.13B. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests strong operational efficiency and the ability to self-fund future innovation or return capital to shareholders, while a decrease may indicate heavy capital expenditure cycles or declining operational profitability.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
High-growth semiconductor and AI infrastructure peers typically prioritize reinvestment, so free cash flow margins are often compared against R&D intensity and capital expenditure requirements of industry rivals.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $230.00M | $230.00M | $230.00M | $7.00M | $680.00M | $6.46B | $2.91B | $1.02B | $246.00M | $1.10B | $1.73B | $236.00M | $1.16B | $836.00M | $1.13B |
| QoQ Change | — | +0.0% | +0.0% | -97.0% | >999% | +850.6% | -55.0% | -65.0% | -75.8% | +346.7% | +57.2% | -86.3% | +390.3% | -27.7% | +35.5% |
| YoY Change | — | — | — | — | +195.7% | >999% | +328.2% | — | -96.2% | -62.3% | +69.7% | -4.1% | +5.3% | -51.6% | +380.1% |